Hearings in the UK’s highest Court concerning patents are rare. In fact, since the Supreme Court was established in place of the House of Lords in October 2009, there has only been one substantive…
The applicability of the obvious to try question has been a thorny issue in UK patent law for some time, and the desire for a party seeking invalidity to apply this test has pervaded many recent…
Note on High Court, 27 November 2012, Actavis/Eli Lilly
Introduction
Last year the English Supreme Court in a copyright case held that there is no doubt that the modern trend is in favour of the…
Liversidge v (1) Owen Mumford Limited (2) Abbott Laboratories Limited
In April 2011, the claimant commenced patent infringement proceedings in the UK Patents County Court (“PCC”) against the…
Miquel Montana’s preliminary comments on the decision of the English High Court in Actavis v Eli Lilly [27th November 2012] provide interesting food for thought.
Since some readers may not be…
When the legislation creating supplementary protection certificates (now consolidated in Regulation 469/2009/EC (the “SPC Regulation”)) was first introduced in 1993 no-one could have foreseen the…
On 10 October 2012, the Court of Appeal handed down its judgment in the case of MedImmune v Novartis*. This was the first of what is expected to be a series of decisions from the Court of Appeal over…
After widespread reform in late 2010 (previously reported here), the Patents County Court (the "PCC") is increasingly becoming a court of choice in intellectual property matters in England and Wales…
The UK IPO has applied the decision of the CJEU in Brüstle on stem cells in a recent case that is likely to lead to more judicial comment on the patentability of stem cell inventions. In…
August and September are traditionally vacation months in the English Courts although the Patents Court can and often does sit in September. As a result of this, not many judgments are handed down in…
